Compare AIP & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIP | INNV |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2021 | 2021 |
| Metric | AIP | INNV |
|---|---|---|
| Price | $22.87 | $10.66 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.83 | $7.00 |
| AVG Volume (30 Days) | ★ 638.3K | 207.6K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.65 | ★ 90.91 |
| EPS | N/A | ★ N/A |
| Revenue | $70,579,000.00 | ★ $989,707,000.00 |
| Revenue This Year | $30.24 | $12.85 |
| Revenue Next Year | $19.50 | $8.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 22.27 | 15.93 |
| 52 Week Low | $8.69 | $3.94 |
| 52 Week High | $50.26 | $12.64 |
| Indicator | AIP | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 43.64 |
| Support Level | $14.44 | $10.09 |
| Resistance Level | $34.03 | $10.69 |
| Average True Range (ATR) | 1.10 | 0.55 |
| MACD | 0.31 | -0.03 |
| Stochastic Oscillator | 52.33 | 12.69 |
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.